Medicare Enrolled

Dr. Craig Deligdish, MD

Medical Oncology · Melbourne, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1344 S APOLLO BLVD, Melbourne, FL 32901
3217273495
In practice since 2005 (20 years)
NPI: 1679564462 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Deligdish from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Deligdish? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Deligdish

Dr. Craig Deligdish is a medical oncology in Melbourne, FL, with 20 years in practice. Based on federal Medicare data, Dr. Deligdish performed 30,774 Medicare services across 692 unique beneficiaries.

Between the years covered by Open Payments, Dr. Deligdish received a total of $2,304 from 31 pharmaceutical and/or device companies across 93 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Deligdish is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 40% volume in FL$ $2,304 industry payments

Medicare Practice Summary

Medicare Utilization ↗
30,774
Medicare services
Top 40% in FL for medical oncology
692
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,539 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Romosozumab injection (Evenity) for osteoporosis22,045$8$18
Denosumab injection (Prolia/Xgeva)6,780$18$38
Office visit, established patient (30-39 min)921$93$218
Drug injection, under skin or into muscle365$11$33
Acupuncture, initial 15 minutes106$30$57
Acupuncture, each additional 15 minutes106$23$44
Injection, zoledronic acid, 1 mg100$7$23
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less95$48$140
Office visit, established patient (20-29 min)87$68$149
Office visit, established patient, complex (40-54 min)68$137$293
Administration of chemotherapy into vein, 1 hour or less59$99$276
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle28$26$61
Joint injection, major joint14$47$124
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
95.5% medium
4.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,304
Total received (2018-2024)
Avg $329/year across 7 years
Bottom 33% in FL for medical oncology
31
Companies
93
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,589 (69.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$714 (31.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,456
2023
$512
2022
$42
2021
$58
2020
$14
2019
$66
2018
$155

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$267
Lilly USA, LLC
$266
AstraZeneca Pharmaceuticals LP
$231
PFIZER INC.
$219
Daiichi Sankyo Inc.
$201
Gilead Sciences, Inc.
$134
Amgen Inc.
$102
Janssen Biotech, Inc.
$99
BeiGene USA, Inc.
$92
Genentech USA, Inc.
$71
Celgene Corporation
$58
UCB, Inc.
$51
Mallinckrodt Hospital Products Inc.
$50
ACCORD HEALTHCARE, INC.
$44
Tempus AI, Inc
$39
GlaxoSmithKline, LLC.
$38
Novartis Pharmaceuticals Corporation
$36
Coherus Biosciences Inc.
$34
Takeda Pharmaceuticals U.S.A., Inc.
$33
PharmaEssentia USA Corporation
$28
TAIHO ONCOLOGY, INC.
$22
Kyowa Kirin, Inc.
$22
Biocon Biologics Inc
$22
AbbVie, Inc.
$22
Radius Health, Inc.
$22
Pharmacyclics LLC, An AbbVie Company
$18
Incyte Corporation
$18
RECORDATI_RARE_DISEASES_INC.
$17
Siemens Medical Solutions USA, Inc.
$17
Ipsen Biopharmaceuticals, Inc
$16
Horizon Pharma plc
$14
Top 3 companies account for 33.2% of total payments
Associated products mentioned in payments ›
ACTHAR · Alecensa · BENLYSTA · BESREMI · BOSULIF · BRUKINSA · CALQUENCE · CAMCEVI · CYRAMZA · Cimzia · DARZALEX · ENHERTU · EVENITY · Enhertu · Gazyva · Hulio · IBRANCE · IMFINZI · INLYTA · Imbruvica · Juniper · KRYSTEXXA · LONSURF · OJJAARA · OPDUALAG · OXBRYTA · PEMAZYRE · PLUVICTO · Perjeta · Poteligeo · REBLOZYL · SYLVANT · Somatuline Depot · TAGRISSO · TECVAYLI · Tymlos · Udenyca · VERZENIO · VONVENDI · Venclexta · XT CDX · XTANDI · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (69%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $7 per 100 Medicare services performed
Looking for a medical oncology in Melbourne?
Compare medical oncologys in the Melbourne area by procedure volume, costs, and industry payment transparency.
Browse medical oncologys nearby

Geographic Context

Medical Oncologys within 10 mi
6
Per 100K population
1.0
County median income
$75,817
Nearest hospital
HOLMES REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Deligdish is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Deligdish experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Deligdish performed 22,045 romosozumab injection (evenity) for osteoporosis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Deligdish receive payments from pharmaceutical companies?
Yes. Dr. Deligdish received a total of $2,304 from 31 companies across 93 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Deligdish's costs compare to other medical oncologys in Melbourne?
Dr. Deligdish's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Deligdish) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →